| Candy Lee Trusty, | |
|
3134 E 79th Ave, Merrillville, IN 46410-5738 | |
| (219) 947-3789 | |
| Not Available |
| Full Name | Candy Lee Trusty |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3134 E 79th Ave, Merrillville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124613690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26015714A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Candy Lee Trusty, 1630 Sand Creek Dr, Chesterton, IN 46304-9374 Ph: (219) 921-6237 | Candy Lee Trusty, 3134 E 79th Ave, Merrillville, IN 46410-5738 Ph: (219) 947-3789 |
News Archive
A drug that is already an approved therapy for some cancers also might be an effective secondary treatment for a rare tumor of the gastrointestinal tract, according to a team led by researchers from the University of Pittsburgh Cancer Institute (UPCI). The findings, based on experiments using cell cultures, were published in the Jan. 1 issue of Cancer Research.
The rapidly emerging field of precision medicine is a "disruptive innovation" that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week's issue of the New England Journal of Medicine.
People who receive care and the adult social care workforce will be further protected from COVID-19 and flu over the coming months, as the government sets additional funding for infection prevention and control.
Pro-Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of Davanat in combination with 5-FU to treat a breast cancer patient at the Brown Cancer Center in Louisville, Kentucky. Davanat also is being administered in Phase II clinical trials for first-line treatment of colorectal and biliary cancer patients.
Looking at the dark stripes on the tiny zebrafish you might not expect that they hold a potentially important clue for discovering a treatment for the deadly skin disease melanoma. Yet melanocytes, the same cells that are are responsible for the pigmentation of zebrafish stripes and for human skin color, are also where melanoma originates.
› Verified 6 days ago
Mrs. Lena Danielle Clouse, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Genoa Healthcare Llc, 8555 Taft Street, Merrillville, IN 46410 Phone: 219-769-8171 Fax: 219-769-8176 | |
Margaret Gurley, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 611 Us Highway 30, Merrillville, IN 46410 Phone: 219-650-3710 Fax: 219-650-3765 | |
Mr. Robert Lee Andrews Jr., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1340 W 90th Place Apt. 104, Merrillville, IN 46410 Phone: 773-563-3869 | |
Ms. Maria Mckenzie Harmon, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 E 81st Ave, Merrillville, IN 46410 Phone: 219-769-0013 | |
Christine Marie Hope, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 E 81st Ave, Merrillville, IN 46410 Phone: 219-769-0013 Fax: 219-359-4019 | |
Voncenia Vann, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5424 Jackson St, Merrillville, IN 46410 Phone: 219-884-4372 |